Combined tramadol and morphine overdose — a rare case report
Abstract
The use of opioids in cancer patients for pain management can improve the quality of life, but it comes with the risk of overdose and the potential risk of suicide. This case report highlights a 42-year-old male cancer patient who attempted suicide by overdosing on morphine and tramadol, both prescribed for pain management. Opioid-induced respiratory depression is the primary cause of death in such cases, which can be reversed with naloxone. The patient was successfully treated with naloxone infusion and supportive measures. Individual risk factors like neuropsychiatric illness, family history of suicidal behavior, and drug and alcohol misuse have a strong predilection for suicide. Identifying and managing opioid overdose is crucial for saving lives, as opioids potentially cause disinhibition and impulsive behavior which can be one of the contributing factors leading to suicide. It is important to screen patients for substance abuse and psychiatric conditions, educate families on managing medications cautiously, and monitor patients closely for signs of suicidal ideation. This case report provides insights into managing a double opioid overdose in cancer patients. Overall, understanding the risks associated with opioid use and implementing appropriate measures for monitoring and intervention can help reduce the incidence of suicide due to opioid overdose in cancer patients.
References
- Dolinak D. Opioid toxicity. Acad Forensic Pathol. 2017; 7(1): 19–35.
- Rzasa Lynn R, Galinkin JL. Naloxone dosage for opioid reversal: current evidence and clinical implications. Ther Adv Drug Saf. 2018; 9(1): 63–88.
- Rafiei S, Pashazadeh Kan F, Raoofi S, et al. Global prevalence of suicide in patients with cancer: A systematic review and meta-analysis. Arch Suicide Res. 2024; 28(3): 723–736.
- Shenoy MS, Khobragade AW, Subramanian M. Suicide trends among patients with cancer in India over the past 24 years. Gen Psychiatr. 2023; 36(6): e101190.
- Schiller EY, Mechanic OJ. Opioid overdose. National Library of Medicine. 2023. https://www.ncbi.nlm.nih.gov/books/NBK470415/ (15.10.2024).
- Bartle S. Drug and alcohol nurse specialist DR. Drug misuse management in the acute hospital setting — guidelines. 3rd ed. Doncaster and Bassetlaw Hospital 2023.
- Rockett IRH, Hobbs G, De Leo D, et al. Suicide and unintentional poisoning mortality trends in the United States, 1987–2006: two unrelated phenomena? BMC Public Health. 2010; 10(1): 705.
- Edwards RR, Smith MT, Kudel I, et al. Pain-related catastrophizing as a risk factor for suicidal ideation in chronic pain. Pain. 2006; 126(1–3): 272–279.
- Chen DTH, Nargis N, Fong GT, et al. A longitudinal study of transitions between smoking and smokeless tobacco use from the ITC Bangladesh Surveys: implications for tobacco control in the Southeast Asia region. Lancet Reg Health Southeast Asia. 2023; 14: 100185.
- Yaworski D, Robinson J, Sareen J, et al. The relation between nicotine dependence and suicide attempts in the general population. Can J Psychiatry. 2011; 56(3): 161–170.
- Fazel S, Runeson Bo. Suicide. N Engl J Med. 2020; 382(3): 266–274.
- Elman I, Borsook D, Volkow ND. Pain and suicidality: insights from reward and addiction neuroscience. Prog Neurobiol. 2013; 109: 1–27.
- Ilgen MA, Bohnert ASB, Ganoczy D, et al. Opioid dose and risk of suicide. Pain. 2016; 157(5): 1079–1084.
- González Lago S, Pérez García MJ, Gomila I, et al. High-sensitivity troponin I elevation and hyperamylasemia in a pediatric case with tramadol and morphine overdose. An Pediatr (Engl Ed). 2022; 97(5): 359–360.
- Nakhaee S, Hoyte C, Dart R, et al. A review on tramadol toxicity: mechanism of action, clinical presentation, and treatment. Forens Toxicol. 2021; 39(2): 293–310.
- Oquendo MA, Volkow ND. Suicide: A silent contributor to opioid-overdose deaths. N Engl J Med. 2018; 378(17): 1567–1569.
- Khan NF, Bateman BT, Landon JE, et al. Association of opioid overdose with opioid prescriptions to family members. JAMA Intern Med. 2019; 179(9): 1186–1192.
